Sergejs Berdnikovs
Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophils | 17 | 2024 | 316 | 6.260 |
Why?
| | Asthma | 14 | 2026 | 1768 | 2.350 |
Why?
| | Respiratory Mucosa | 5 | 2026 | 322 | 2.050 |
Why?
| | Respiratory Syncytial Virus Infections | 4 | 2026 | 136 | 1.780 |
Why?
| | Hypersensitivity | 7 | 2021 | 252 | 1.780 |
Why?
| | Epithelial Cells | 7 | 2025 | 1126 | 1.750 |
Why?
| | Neutrophils | 4 | 2024 | 1134 | 1.540 |
Why?
| | Respiratory Sounds | 3 | 2026 | 105 | 1.260 |
Why?
| | Pneumonia | 4 | 2023 | 631 | 1.200 |
Why?
| | Interleukin-5 | 4 | 2024 | 39 | 1.160 |
Why?
| | Inflammation | 8 | 2023 | 2880 | 1.100 |
Why?
| | Epithelium | 2 | 2020 | 314 | 1.050 |
Why?
| | Mice, Inbred BALB C | 13 | 2025 | 1253 | 0.970 |
Why?
| | Homeostasis | 3 | 2021 | 640 | 0.940 |
Why?
| | Extracellular Matrix | 3 | 2020 | 553 | 0.880 |
Why?
| | Single-Cell Analysis | 2 | 2025 | 359 | 0.870 |
Why?
| | Monocytes | 4 | 2021 | 538 | 0.800 |
Why?
| | Antigens, Ly | 2 | 2021 | 40 | 0.790 |
Why?
| | Granulocyte Precursor Cells | 2 | 2024 | 10 | 0.780 |
Why?
| | Lung | 12 | 2025 | 4109 | 0.770 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 3 | 2012 | 44 | 0.750 |
Why?
| | Chemotaxis, Leukocyte | 3 | 2015 | 113 | 0.750 |
Why?
| | Cell Differentiation | 10 | 2025 | 2050 | 0.740 |
Why?
| | Fibrinogen | 2 | 2021 | 177 | 0.720 |
Why?
| | Interleukin-5 Receptor alpha Subunit | 2 | 2021 | 6 | 0.720 |
Why?
| | Myeloid Progenitor Cells | 1 | 2021 | 17 | 0.680 |
Why?
| | Insulins | 1 | 2021 | 38 | 0.660 |
Why?
| | Mast Cells | 3 | 2020 | 146 | 0.660 |
Why?
| | Wound Healing | 2 | 2020 | 351 | 0.640 |
Why?
| | Mice | 26 | 2025 | 18365 | 0.610 |
Why?
| | Endocrine Disruptors | 1 | 2020 | 45 | 0.600 |
Why?
| | Disease Susceptibility | 1 | 2021 | 348 | 0.600 |
Why?
| | Bone Marrow Cells | 6 | 2021 | 320 | 0.590 |
Why?
| | Benzhydryl Compounds | 1 | 2020 | 82 | 0.590 |
Why?
| | Animals | 34 | 2025 | 38109 | 0.590 |
Why?
| | Mesoderm | 1 | 2020 | 150 | 0.580 |
Why?
| | Phenols | 1 | 2020 | 114 | 0.580 |
Why?
| | Coronavirus Infections | 2 | 2021 | 378 | 0.580 |
Why?
| | CD11c Antigen | 2 | 2015 | 40 | 0.570 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 3 | 2012 | 40 | 0.560 |
Why?
| | Tenascin | 1 | 2018 | 15 | 0.560 |
Why?
| | Blood Coagulation | 1 | 2020 | 268 | 0.550 |
Why?
| | Receptors, IgE | 3 | 2023 | 43 | 0.530 |
Why?
| | Cells, Cultured | 10 | 2022 | 4155 | 0.530 |
Why?
| | Immunophenotyping | 2 | 2015 | 322 | 0.520 |
Why?
| | Gene Expression Profiling | 7 | 2024 | 1786 | 0.520 |
Why?
| | Leukocytes | 4 | 2012 | 295 | 0.520 |
Why?
| | Gene Expression Regulation | 5 | 2020 | 2609 | 0.500 |
Why?
| | Phenotype | 4 | 2025 | 3164 | 0.490 |
Why?
| | Gene Expression | 1 | 2021 | 1490 | 0.480 |
Why?
| | Hematopoiesis | 3 | 2018 | 194 | 0.470 |
Why?
| | Tetraspanin 24 | 1 | 2015 | 7 | 0.460 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2925 | 0.460 |
Why?
| | Sex Characteristics | 4 | 2025 | 791 | 0.450 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2017 | 220 | 0.450 |
Why?
| | Inflammation Mediators | 3 | 2015 | 509 | 0.440 |
Why?
| | Influenza, Human | 1 | 2021 | 617 | 0.440 |
Why?
| | Energy Metabolism | 1 | 2021 | 936 | 0.440 |
Why?
| | Immunomodulation | 1 | 2015 | 101 | 0.420 |
Why?
| | Ovalbumin | 5 | 2025 | 190 | 0.410 |
Why?
| | Cytokines | 8 | 2025 | 2065 | 0.400 |
Why?
| | Nasal Polyps | 3 | 2020 | 59 | 0.390 |
Why?
| | Vitamin E | 2 | 2012 | 121 | 0.370 |
Why?
| | Rhinitis | 3 | 2020 | 171 | 0.350 |
Why?
| | Mice, Knockout | 6 | 2022 | 3125 | 0.340 |
Why?
| | Sinusitis | 3 | 2020 | 229 | 0.330 |
Why?
| | Down-Regulation | 2 | 2011 | 627 | 0.310 |
Why?
| | Humans | 33 | 2026 | 144957 | 0.310 |
Why?
| | Interleukin-33 | 3 | 2020 | 45 | 0.310 |
Why?
| | Immunoglobulin E | 3 | 2023 | 315 | 0.310 |
Why?
| | Respiratory Tract Infections | 2 | 2026 | 398 | 0.300 |
Why?
| | Up-Regulation | 2 | 2011 | 852 | 0.300 |
Why?
| | Female | 20 | 2026 | 78376 | 0.300 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4569 | 0.290 |
Why?
| | alpha-Tocopherol | 3 | 2014 | 32 | 0.290 |
Why?
| | Basophils | 2 | 2020 | 52 | 0.280 |
Why?
| | Carbon Dioxide | 2 | 2020 | 242 | 0.270 |
Why?
| | Male | 19 | 2026 | 72406 | 0.270 |
Why?
| | Cell Degranulation | 2 | 2019 | 42 | 0.270 |
Why?
| | Endothelial Cells | 3 | 2012 | 870 | 0.260 |
Why?
| | Cell Adhesion | 3 | 2019 | 455 | 0.260 |
Why?
| | CD11b Antigen | 2 | 2019 | 60 | 0.260 |
Why?
| | Biomarkers | 6 | 2021 | 4275 | 0.260 |
Why?
| | Asthma, Aspirin-Induced | 2 | 2017 | 3 | 0.250 |
Why?
| | Wnt Signaling Pathway | 2 | 2019 | 210 | 0.240 |
Why?
| | Signal Transduction | 7 | 2022 | 5233 | 0.240 |
Why?
| | Transcriptome | 3 | 2024 | 1046 | 0.240 |
Why?
| | Glucose | 2 | 2021 | 1049 | 0.230 |
Why?
| | Child, Preschool | 5 | 2026 | 11799 | 0.230 |
Why?
| | Cell Line | 6 | 2020 | 2882 | 0.230 |
Why?
| | Eosinophilia | 2 | 2021 | 221 | 0.230 |
Why?
| | Mice, Inbred C57BL | 8 | 2020 | 5997 | 0.220 |
Why?
| | Granulocytes | 1 | 2024 | 80 | 0.220 |
Why?
| | B-Lymphocyte Subsets | 1 | 2025 | 80 | 0.210 |
Why?
| | Pelvic Bones | 1 | 2007 | 135 | 0.210 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 2 | 2021 | 9 | 0.200 |
Why?
| | Nasal Lavage Fluid | 3 | 2020 | 15 | 0.200 |
Why?
| | Metabolic Diseases | 1 | 2024 | 114 | 0.190 |
Why?
| | Receptors, Adiponectin | 1 | 2022 | 22 | 0.190 |
Why?
| | gamma-Tocopherol | 2 | 2013 | 8 | 0.190 |
Why?
| | Myeloid Cells | 2 | 2021 | 148 | 0.180 |
Why?
| | Infant | 4 | 2026 | 10039 | 0.180 |
Why?
| | Computational Biology | 2 | 2017 | 681 | 0.180 |
Why?
| | Estrogens | 2 | 2020 | 380 | 0.180 |
Why?
| | Scleroderma, Systemic | 1 | 2022 | 123 | 0.170 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2021 | 58 | 0.170 |
Why?
| | Coronavirus 229E, Human | 1 | 2021 | 7 | 0.170 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 1 | 2021 | 11 | 0.170 |
Why?
| | Leukopoiesis | 1 | 2021 | 11 | 0.170 |
Why?
| | Nasal Cavity | 1 | 2021 | 62 | 0.170 |
Why?
| | Orthomyxoviridae | 1 | 2021 | 40 | 0.170 |
Why?
| | Stromal Cells | 1 | 2021 | 125 | 0.160 |
Why?
| | Chemotaxis | 1 | 2021 | 122 | 0.160 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2020 | 56 | 0.160 |
Why?
| | Dietary Supplements | 3 | 2014 | 576 | 0.160 |
Why?
| | Eosinophil Major Basic Protein | 1 | 2019 | 7 | 0.160 |
Why?
| | Metabolic Networks and Pathways | 1 | 2021 | 187 | 0.160 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2015 | 636 | 0.160 |
Why?
| | Secretory Vesicles | 1 | 2019 | 24 | 0.150 |
Why?
| | B-Lymphocytes | 1 | 2025 | 877 | 0.150 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2019 | 157 | 0.150 |
Why?
| | Disease | 1 | 2020 | 98 | 0.150 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2019 | 223 | 0.150 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 573 | 0.150 |
Why?
| | Drug Hypersensitivity | 1 | 2020 | 90 | 0.140 |
Why?
| | Administration, Inhalation | 1 | 2020 | 575 | 0.140 |
Why?
| | Cell Death | 1 | 2019 | 383 | 0.140 |
Why?
| | Gene Regulatory Networks | 2 | 2017 | 320 | 0.130 |
Why?
| | Cell Survival | 1 | 2021 | 1098 | 0.130 |
Why?
| | Drosophila melanogaster | 1 | 2019 | 236 | 0.130 |
Why?
| | Macrophages, Alveolar | 2 | 2017 | 368 | 0.130 |
Why?
| | Cellular Microenvironment | 1 | 2018 | 94 | 0.130 |
Why?
| | Lung Injury | 1 | 2020 | 237 | 0.130 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2017 | 8 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Cell Movement | 4 | 2020 | 965 | 0.130 |
Why?
| | Extracellular Matrix Proteins | 1 | 2018 | 159 | 0.120 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 1 | 2016 | 22 | 0.120 |
Why?
| | Caenorhabditis elegans | 1 | 2019 | 337 | 0.120 |
Why?
| | Cell-Derived Microparticles | 1 | 2017 | 75 | 0.120 |
Why?
| | Aging | 1 | 2007 | 1966 | 0.120 |
Why?
| | Metabolomics | 1 | 2021 | 727 | 0.120 |
Why?
| | Passive Cutaneous Anaphylaxis | 1 | 2015 | 3 | 0.120 |
Why?
| | Protein Kinase C-alpha | 2 | 2012 | 37 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Protein Isoforms | 3 | 2013 | 402 | 0.110 |
Why?
| | beta Catenin | 1 | 2017 | 253 | 0.110 |
Why?
| | Mitochondria | 1 | 2021 | 984 | 0.110 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 592 | 0.100 |
Why?
| | Chemokines | 2 | 2012 | 218 | 0.100 |
Why?
| | Cohort Studies | 2 | 2022 | 5965 | 0.100 |
Why?
| | Anaphylaxis | 1 | 2015 | 102 | 0.100 |
Why?
| | Infant, Newborn | 2 | 2026 | 6434 | 0.100 |
Why?
| | Antioxidants | 2 | 2014 | 549 | 0.100 |
Why?
| | Phosphorylation | 2 | 2015 | 1733 | 0.100 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 311 | 0.100 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2015 | 381 | 0.100 |
Why?
| | Allergens | 2 | 2017 | 384 | 0.100 |
Why?
| | Arthritis, Experimental | 1 | 2014 | 141 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 437 | 0.100 |
Why?
| | Eosinophilic Esophagitis | 1 | 2017 | 330 | 0.090 |
Why?
| | Pulmonary Fibrosis | 1 | 2017 | 395 | 0.090 |
Why?
| | 5-Hydroxytryptophan | 1 | 2012 | 19 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2021 | 1241 | 0.090 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2012 | 56 | 0.090 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 1098 | 0.090 |
Why?
| | Models, Biological | 1 | 2020 | 1822 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2020 | 2499 | 0.090 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2012 | 138 | 0.090 |
Why?
| | Receptors, Chemokine | 1 | 2011 | 47 | 0.090 |
Why?
| | Cytoplasm | 1 | 2012 | 269 | 0.090 |
Why?
| | Macrophages | 2 | 2017 | 1511 | 0.090 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2011 | 30 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1695 | 0.090 |
Why?
| | Immunologic Factors | 1 | 2013 | 255 | 0.090 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 269 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 138 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 175 | 0.080 |
Why?
| | Th2 Cells | 1 | 2011 | 171 | 0.080 |
Why?
| | Dendritic Cells | 1 | 2014 | 499 | 0.080 |
Why?
| | Respiratory Hypersensitivity | 1 | 2011 | 65 | 0.080 |
Why?
| | Transcription, Genetic | 1 | 2017 | 1496 | 0.080 |
Why?
| | Blotting, Western | 2 | 2011 | 1187 | 0.080 |
Why?
| | Hypercapnia | 2 | 2020 | 54 | 0.080 |
Why?
| | Plant Oils | 1 | 2009 | 31 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3415 | 0.070 |
Why?
| | Tissue Array Analysis | 2 | 2019 | 50 | 0.070 |
Why?
| | Bleomycin | 2 | 2022 | 253 | 0.070 |
Why?
| | Dermatitis, Atopic | 1 | 2011 | 321 | 0.070 |
Why?
| | Fibrosis | 2 | 2022 | 548 | 0.070 |
Why?
| | Obesity | 1 | 2021 | 3082 | 0.070 |
Why?
| | Chronic Disease | 3 | 2020 | 1813 | 0.060 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2014 | 675 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2019 | 341 | 0.060 |
Why?
| | Bone Remodeling | 1 | 2007 | 71 | 0.060 |
Why?
| | Calcium | 1 | 2012 | 1184 | 0.060 |
Why?
| | Sexual Behavior, Animal | 1 | 2007 | 57 | 0.060 |
Why?
| | Adult | 4 | 2024 | 40506 | 0.060 |
Why?
| | Sex Factors | 2 | 2025 | 2114 | 0.060 |
Why?
| | Androgens | 1 | 2007 | 186 | 0.060 |
Why?
| | Reproduction | 1 | 2007 | 207 | 0.060 |
Why?
| | Macrophage Activation | 2 | 2017 | 193 | 0.050 |
Why?
| | Radiography | 1 | 2007 | 845 | 0.050 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2022 | 12 | 0.050 |
Why?
| | Ubiquitins | 1 | 2022 | 33 | 0.050 |
Why?
| | Adipocytes | 1 | 2024 | 223 | 0.050 |
Why?
| | Rats | 2 | 2011 | 5614 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2007 | 781 | 0.050 |
Why?
| | Eosinophil Granule Proteins | 1 | 2021 | 15 | 0.040 |
Why?
| | Biological Factors | 1 | 2021 | 39 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2540 | 0.040 |
Why?
| | Integrin beta Chains | 1 | 2020 | 7 | 0.040 |
Why?
| | Chemokine CXCL12 | 1 | 2020 | 89 | 0.040 |
Why?
| | Receptors, CXCR4 | 1 | 2020 | 91 | 0.040 |
Why?
| | Chemokine CXCL1 | 1 | 2020 | 76 | 0.040 |
Why?
| | Respiratory Tract Diseases | 1 | 2021 | 175 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 479 | 0.040 |
Why?
| | Research Design | 1 | 2026 | 1137 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2024 | 653 | 0.040 |
Why?
| | T-Lymphocyte Subsets | 1 | 2022 | 415 | 0.040 |
Why?
| | Neutrophil Infiltration | 1 | 2020 | 104 | 0.040 |
Why?
| | Alveolar Epithelial Cells | 1 | 2020 | 120 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2021 | 377 | 0.040 |
Why?
| | Virus Diseases | 1 | 2021 | 216 | 0.040 |
Why?
| | Respiratory System | 1 | 2020 | 149 | 0.040 |
Why?
| | Pregnancy | 2 | 2026 | 7191 | 0.030 |
Why?
| | Bronchi | 1 | 2019 | 267 | 0.030 |
Why?
| | Cell Communication | 1 | 2020 | 324 | 0.030 |
Why?
| | Skin | 1 | 2022 | 758 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 735 | 0.030 |
Why?
| | Fibroblasts | 1 | 2022 | 1034 | 0.030 |
Why?
| | NF-kappa B | 1 | 2020 | 662 | 0.030 |
Why?
| | Immunity | 1 | 2017 | 139 | 0.030 |
Why?
| | Interleukins | 1 | 2017 | 248 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2023 | 2832 | 0.030 |
Why?
| | Immunoassay | 1 | 2015 | 109 | 0.030 |
Why?
| | Biomedical Research | 1 | 2021 | 710 | 0.030 |
Why?
| | Cell Lineage | 1 | 2016 | 376 | 0.030 |
Why?
| | Prospective Studies | 1 | 2026 | 7997 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 851 | 0.020 |
Why?
| | Pyroglyphidae | 1 | 2012 | 18 | 0.020 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2012 | 44 | 0.020 |
Why?
| | Xanthine Oxidase | 1 | 2012 | 79 | 0.020 |
Why?
| | Endothelium | 1 | 2012 | 119 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2012 | 396 | 0.020 |
Why?
| | Microcirculation | 1 | 2012 | 138 | 0.020 |
Why?
| | Butadienes | 1 | 2011 | 37 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2014 | 902 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2012 | 206 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 173 | 0.020 |
Why?
| | DNA Primers | 1 | 2012 | 512 | 0.020 |
Why?
| | Cell Adhesion Molecules | 1 | 2012 | 178 | 0.020 |
Why?
| | Middle Aged | 3 | 2020 | 35928 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 331 | 0.020 |
Why?
| | Flavonoids | 1 | 2011 | 87 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2011 | 76 | 0.020 |
Why?
| | NADPH Oxidases | 1 | 2011 | 124 | 0.020 |
Why?
| | Cysteine | 1 | 2012 | 210 | 0.020 |
Why?
| | Nitriles | 1 | 2011 | 205 | 0.020 |
Why?
| | Spleen | 1 | 2012 | 508 | 0.020 |
Why?
| | Serotonin | 1 | 2012 | 294 | 0.020 |
Why?
| | Binding Sites | 1 | 2012 | 1331 | 0.020 |
Why?
| | Base Sequence | 1 | 2012 | 2191 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 2157 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2011 | 826 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2931 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2015 | 3608 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2185 | 0.020 |
Why?
| | Oxygen | 1 | 2012 | 995 | 0.020 |
Why?
| | Diet | 1 | 2013 | 1275 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 2011 | 965 | 0.010 |
Why?
| | Child | 1 | 2022 | 22657 | 0.010 |
Why?
| | Aged | 1 | 2015 | 25947 | 0.010 |
Why?
|
|
Berdnikovs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|